A Patient-Centric Approach to Clinical Trial Recruitment & Retention

Clinical Trials, Life Sciences, Patient Recruitment & Retention,
  • Monday, October 28, 2019

Patient recruitment continues to be the number one reason for study delays. It is estimated for every day a drug is not on the market, $1 million USD is lost in revenue, and more importantly, patients suffering from illnesses are left waiting for products that can help them achieve their health goals or provide a better quality of life.

This webinar examines techniques used to ensure on-time patient recruitment initiatives including the following:

  • Feasibility process — what questions to ask to ensure the best sites are being selected for a particular program
  • Site engagement and why it’s critical to the success of a study and how to achieve it
  • Digital media strategies
  • Patient centricity: How to incorporate the patient voice into clinical trials

Speakers

Shaheen Limbada, Executive VP of Global Clinical Operations, Veristat

Shaheen Limbada oversees patient recruitment, site engagement, site monitoring and site management teams. With over 20 years of experience running clinical trials, he excels in the areas of organizational development and execution, patient recruitment and retention, clinical study conduct and governance and drug safety monitoring. He joined Veristat through the recent acquisition of Topstone Research, a Canadian-based CRO that he co-founded and held the position of managing director. Prior to Topstone, he worked in clinical operations, project management and leadership roles at various clinical research organizations (CROs) and pharmaceutical firms including Leo Pharma, Cetero Research and AstraZeneca.

Message Presenter

Deepen Patel, MD, CCFP, Vice President of Medical Affairs, Veristat

Dr. Deepen Patel has over 29 years of experience in family practice, clinical research and general corporate administration. With more than 25 years of clinical trial experience, Dr. Patel brings expertise from being an investigator in over 650 Phase 1-4 clinical trials and is a medical monitor and advisor in several studies in many therapeutic fields. Prior to Veristat, Dr. Patel was the senior medical director and principal investigator at an early- and late-phase CRO as well as a part-time family physician, with experience in hospital and emergency department patient care. At Veristat, Dr. Patel oversees the patient safety, pharmacovigilance, medical monitoring and study feasibility services.

Message Presenter

Who Should Attend?

This webinar will benefit executives at start-up and emerging biotech as well as clinical operations, patient recruitment and site monitoring/management heads at small to mid-sized pharmaceutical/biotech companies. Specific job titles include: 

  • Heads, VPs, Directors, Managers of Clinical Operations
  • CEO
  • CMO
  • COO

What You Will Learn

Attendees will gain insights into: 

  • The feasibility process — what questions to ask to ensure the best sites are being selected for a particular program
  • Site engagement and why it’s critical to the success of a study and how to achieve it
  • Digital media strategies
  • Patient centricity: How to incorporate the patient voice into clinical trials

Xtalks Partner

Veristat

Veristat is a scientifically oriented and impactful full-service clinical research organization (CRO) that is committed to partnering with emerging and small to mid-sized biotechnology firms to advance their therapies throughout the entire clinical development and regulatory submission process. Our team helps growing clients solve the unique and complex challenges that arise when trying to accelerate therapies along the development pathway to successful regulatory approval, beginning with regulatory planning, study design, protocol development, site selection and start-up through to patient recruitment, clinical monitoring, data collection, analysis and reporting. Ultimately, we guide our clients to market success so that their therapies become available to improve and save people’s lives. Our impact is proven by our regulatory track record of success —  in 2018, Veristat supported 12 percent of all NMEs approval by the FDA.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account